'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance

被引:255
作者
Di Marzo, V [1 ]
机构
[1] CNR, Ist Chim Mol Interesse Biol, Natl Inst Chem Biol Syst, I-80072 Naples, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1998年 / 1392卷 / 2-3期
关键词
cannabinoid; anandamide; arachidonic acid; eicosanoid; oleamide; 2-arachidonoyl-glycerol;
D O I
10.1016/S0005-2760(98)00042-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The only endogenous substances isolated and characterised so Ear that are capable of mimicking the pharmacological actions of the active principle of marijuana, (-)-Delta(9)-tetrahydrocannabinol, are amides and esters of fatty acids. Some of these compounds, like anandamide (N-arachidonoylethanolamine) and 2-arachidonoylglycerol, act as true 'endogenous cannabinoids' by binding and functionally activating one or both cannabinoid receptor subtypes present on nervous and peripheral cell membranes, The metabolic pathways and molecular mode of actions of these metabolites, as well as their possible implication in physiopathological responses, are reviewed here. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:153 / 175
页数:23
相关论文
共 205 条
[61]   ANANDAMIDE, AN ENDOGENOUS CANNABIMIMETIC EICOSANOID, BINDS TO THE CLONED HUMAN CANNABINOID RECEPTOR AND STIMULATES RECEPTOR-MEDIATED SIGNAL-TRANSDUCTION [J].
FELDER, CC ;
BRILEY, EM ;
AXELROD, J ;
SIMPSON, JT ;
MACKIE, K ;
DEVANE, WA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7656-7660
[62]  
FernandezRuiz J, 1997, BIOCHEM PHARMACOL, V53, P1919
[63]   Evidence that methyl arachidonyl fluorophosphate is an irreversible cannabinoid receptor antagonist [J].
Fernando, SR ;
Pertwee, RG .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) :1716-1720
[64]   ANALYSIS OF ANANDAMIDE, AN ENDOGENOUS CANNABINOID SUBSTANCE, AND OF OTHER NATURAL N-ACYLETHANOLAMINES [J].
FONTANA, A ;
DIMARZO, V ;
CADAS, H ;
PIOMELLI, D .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1995, 53 (04) :301-308
[65]  
Fowler CJ, 1997, J PHARMACOL EXP THER, V283, P729
[66]   PHARMACOLOGICAL ACTIVITY OF THE CANNABINOID RECEPTOR AGONIST, ANANDAMIDE, A BRAIN CONSTITUENT [J].
FRIDE, E ;
MECHOULAM, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (02) :313-314
[67]  
FRIDE E, 1995, J PHARMACOL EXP THER, V272, P699
[68]   Developmental aspects of anandamide: Ontogeny of response and prenatal exposure [J].
Fride, E ;
Mechoulam, R .
PSYCHONEUROENDOCRINOLOGY, 1996, 21 (02) :157-172
[69]  
FRIDE E, 1997, SOC NEUR ABSTR, V23
[70]   ISOLATION, STRUCTURE, AND PARTIAL SYNTHESIS OF AN ACTIVE CONSTITUENT OF HASHISH [J].
GAONI, Y ;
MECHOULAM, R .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (08) :1646-+